Vishal Bhupatbhai Sambada, MBBS, MD – FDA Inspection, Aug 23, 2024

Record Details

This FDA Inspection record concerns Vishal Bhupatbhai Sambada, MBBS, MD, with an inspection on August 23, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Vishal Bhupatbhai Sambada, MBBS, MD
Inspection Date: August 23, 2024
Product Type: Drugs
Office: Center for Drug Evaluation and Research
Person: Emily A. Baldwin (Company Rep)

View Company Profile

ID · f0c6d742-7707-4256-b553-6c21e5d502f9

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number: 1248362
FDA center: Human Drugs
Project area: Bioresearch Monitoring

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Vishal Bhupatbhai Sambada, MBBS, MD

FDA Inspection

Vishal Bhupatbhai Sambada, MBBS, MDAugust 23, 2024